Free tool
Oncology stocks
We cover 31 companies grouped under the Oncology theme. The median market value in the group is $109.87M. Across the group, the median move over the past trading day is +2.59%. 94% of the 31 with a 200-day average trade above it. Price change over the past year runs from −28.3% to +390.1% across the middle 80 percent of the group, with a median of +48.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
31 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% |
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% |
| 4588.T | Oncolys BioPharma Inc. | $716.01M | Small cap | +526.71% |
| 0SZI.L | Corbus Pharmaceuticals Holdings, Inc. | $707.84M | Small cap | +5.13% |
| PRLD | Prelude Therapeutics Incorporated | $524.86M | Small cap | +418.90% |
| 0LOV.L | Verastem, Inc. | $470.33M | Small cap | −21.47% |
| 0XOD.L | UroGen Pharma Ltd. | $347.24M | Small cap | +136.32% |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +100.70% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.75M | Small cap | +14.36% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +98.31% |
| HBP.TO | Helix BioPharma Corp. | $109.87M | Small cap | +35.37% |
| 0QXX.L | Molecular Partners AG | $79.34M | Micro cap | +22.73% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +318.64% |
| SAR.L | Sareum Holdings plc | $70.74M | Micro cap | +38.10% |
| 4572.T | Carna Biosciences, Inc. | $55.69M | Micro cap | +83.26% |
| HOWL | Werewolf Therapeutics, Inc. | $42.93M | Micro cap | −35.04% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.57% |
| KYNB | Kyntra Bio, Inc. | $32.80M | Micro cap | −23.80% |
| BFRI | Biofrontera Inc. | $22.43M | Micro cap | +63.77% |
| ALTME.PA | TME Pharma N.V. | $14.30M | Micro cap | +48.57% |
| CRTX.L | CRISM Therapeutics Corporation | $12.43M | Micro cap | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $10.14M | Micro cap | −40.63% |
| 0NWK.L | Valerio Therapeutics Société anonyme | $10.08M | Micro cap | +1214.52% |
| XBIO | Xenetic Biosciences, Inc. | $8.93M | Micro cap | +33.57% |
| CURX | Curanex Pharmaceuticals Inc | $7.45M | Micro cap | +18.16% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +260.94% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.